When Discovery Becomes the Risk: Lessons from Otsuka v Generic Health (No 4)

A Federal Court decision refusing excessive late-stage discovery shows how quickly litigation costs can escalate without structural safeguards. This article explains the judgment, its relevance today, and how Clean Law’s cost-alignment model is designed to prevent similar risks.